For Your Help

RGCC (Research Genetic Cancer Centre) is a Swiss-based molecular diagnostics company specializing in cancer. Its Circulating Tumor Cell (CTC) analysis and sensitivity testing help us understand your cancer’s molecular behavior, predict recurrence risk, and identify which natural agents, nutrients, or pharmaceuticals may be most effective for your tumor.

All Gerson practitioners at S-Gerson China, Shangri-La are formally trained by RGCC Southeast Asia. They are proficient in interpreting CTC and sensitivity reports and applying them throughout your recovery journey.

We integrate these findings with Gerson Therapy to offer evidence-based tracking and personalized care—so every treatment decision is grounded in data, and every step is clear, measurable, and confidently taken.

This is a way to see healing through the lens of science—and to anchor hope in real, observable progress.